FDA releases updated draft guidance for ANA test systems
Device Regulation Alert: Safety, Compliance and Reimbursement News, February 9, 2009
New developments for in vitro diagnostic devices prompted the FDA to release a revised guidance document, “Recommendations for Anti-Nuclear Antibody (ANA) Test System Premarket (510(k)) Submissions.”
This revised guidance applies only to in vitro diagnostic devices that detect anti-nuclear antibodies as an aid in the diagnosis of autoimmune disease, not tests that differentially diagnose autoimmune diseases.
Comments
0 comments on “FDA releases updated draft guidance for ANA test systems ”
Related Products
Most Popular
- Articles
-
- HIPAA Q&A: Flu shot requirement for hospital employees
- Running an effective peer review committee meeting
- HealthDataInsights posts new issues for medical necessity claims
- Sneak Peek: Effort underway to establish caseload benchmarks
- Q/A: Coding for telescopic intraocular lens
- New FAQ posted on storing laryngoscope blades
- Tip: Perform your own internal investigation prior to government audit
- HIPAA 5010 deadline extended, but threat remains, says AMA
- HHS task force: Consider privacy, security with text messages
- What does case-mix index mean to you?
- E-mailed
-
- Running an effective peer review committee meeting
- HIPAA Q&A: Flu shot requirement for hospital employees
- HHS task force: Consider privacy, security with text messages
- What does case-mix index mean to you?
- Q/A: Coding for telescopic intraocular lens
- Q/A: Correct use of modifier -PT
- Tip: Correctly code bilateral pain management procedures
- "Wall fountains" may be spreading Legionnaires to patients, visitors
- 2012 CPT code changes for ASCs: Shoulder and knee scopes and pain management
- COT basics to best
- Searched
